Home › Calculator › CLNN Dividend Calculator 2026
CLNN Dividend DRIP Calculator 2026
32.79% YieldHealthcareClene Inc. · NASDAQ
Price: $6.10 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CLNN pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CLNN snowball 📈
$10,000 in CLNN → $44339195.39M in 10 years · $3,683,960,216,291.70/month
About Clene Inc. (CLNN) — Dividend Analysis 2026
Clene Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to the discovery, advancement, and market introduction of pioneering therapeutic agents utilizing clean-surfaced nanotechnology (CSN). CNM-Au8 stands as its flagship compound, currently under evaluation across a diverse range of clinical studies. This includes a pivotal Phase 2/3 study intended for regulatory submission in individuals battling amyotrophic lateral sclerosis (ALS). The company has successfully concluded a Phase 2 proof-of-concept trial for those with early manifestations of ALS. Furthermore, two open-label, investigator-blinded Phase 2 trials assessing brain energy metabolism have been finished. An ongoing Phase 2 trial is investigating CNM-Au8's potential to mitigate visual pathway deficits stemming from chronic optic neuropathy, aiming for remyelination in stable relapsing Multiple Sclerosis patients. A Phase 2 clinical investigation targeting Parkinson's Disease patients is also slated for commencement. Beyond its leading candidate, Clene's pipeline extends to include CNM-AgZn17. This gel formulation, comprising silver and zinc ions, is in development to combat infectious diseases and hasten wound recovery. Additionally, CNM-ZnAg acts as a broad-spectrum antiviral and antibacterial compound, designed to address various infectious conditions like COVID-19, while also offering immune support for symptom alleviation. For oncology, CNM-PtAu7 is a gold-platinum CSN therapeutic agent currently in development. The company also distributes dietary supplements, featuring rMetx, a liquid supplement containing zinc-silver ions, and KHC46, an aqueous gold supplement with trace amounts of gold nanoparticles. Clene Inc. maintains its headquarters in Salt Lake City, Utah.
Compare CLNN with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CLNN DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CLNN position with:
🌍 CLNN Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CLNN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 32.79% | 29.99% | $3,279 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 27.87% | 25.07% | $2,787 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 26.23% | 23.43% | $2,623 / yr |
| 🇬🇧 UK ISA | 0% | 32.79% | 29.99% | $3,279 / yr |
| 🇬🇧 UK Taxable | 8.75% | 29.92% | 27.12% | $2,992 / yr |
| 🇨🇦 TFSA | 0% | 32.79% | 29.99% | $3,279 / yr |
| 🇨🇦 CA Taxable | 25% | 24.59% | 21.79% | $2,459 / yr |
| 🇦🇺 Super (pension) | 15% | 27.87% | 25.07% | $2,787 / yr |
| 🇦🇺 AU Taxable | 30% | 22.95% | 20.15% | $2,295 / yr |
| 🇩🇪 DE Taxable | 26.375% | 24.14% | 21.34% | $2,414 / yr |
| 🇫🇷 FR Taxable | 30% | 22.95% | 20.15% | $2,295 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CLNN Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CLNN Dividend Payment Schedule
CLNN pays quarterly — 4 times per year. Next ex-div: TBD.
📊 CLNN vs Healthcare Benchmarks
How CLNN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CLNN sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CLNN Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-11 | 45,000 | $5.53 | $248.8K | ||
| A-Award | 2026-06-11 | 65,000 | $5.53 | $359.4K | ||
| A-Award | 2026-06-11 | 15,000 | $5.53 | $83.0K | ||
| A-Award | 2026-05-21 | 2,064 | $6.81 | $14.1K | ||
| A-Award | 2026-05-21 | 1,500 | $6.81 | $10.2K | ||
| A-Award | 2026-05-21 | 2,158 | $6.81 | $14.7K | ||
| A-Award | 2026-05-21 | 1,500 | $6.81 | $10.2K | ||
| A-Award | 2026-05-21 | 2,861 | $6.81 | $19.5K | ||
| A-Award | 2026-05-21 | 1,500 | $6.81 | $10.2K | ||
| A-Award | 2026-05-21 | 3,659 | $6.81 | $24.9K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CLNN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Clene Inc. (CLNN) is currently trading at $6.10, 98% below its 52-week high. The current dividend yield is 32.79% based on an annual payout of $2.00 per share.
CLNN (Clene Inc.) — 32.79% Dividend Yield Analysis
Clene Inc. (CLNN) is a healthcare stock currently trading at $6.10 with a dividend yield of 32.79%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (32.79%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.